HIGH DOSE THERAPY AND STEM CELL RESCUE IN MANTLE CELL LYMPHOMA: THE MCL0208 TRIAL FROM FONDAZIONE ITALIANA LINFOMI

被引:0
|
作者
Clerico, M. [1 ,2 ]
Ferrero, S. [1 ,2 ]
Alessandria, B. [2 ]
De Luca, G. [2 ]
Grimaldi, D. [2 ]
Genuardi, E. [2 ]
Zaccaria, G. M. [3 ]
Drandi, D. [2 ]
Cavallo, F. [1 ,2 ]
Mantoan, B. [2 ]
Ghislieri, M. [4 ]
Hohaus, S. [5 ]
Musuraca, G. [6 ]
Scalzulli, P. R. [7 ]
Ghiggi, C. [8 ]
Tani, M. [9 ]
Gaidano, G. [10 ]
Volpetti, S. [11 ]
Cabras, G. [12 ]
Di Renzo, N. [13 ]
Merli, F. [14 ]
Vallisa, D. [15 ]
Michieli, M. [16 ]
Pascarella, A. [17 ]
Cortelazzo, S. [18 ]
Ladetto, M. [10 ,19 ]
机构
[1] AOU Citta Salute & Sci Torino, Div Hematol, Turin, Italy
[2] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[3] Ist Tumori Giovanni Paolo II, IRCCS, Hematol & Cell Therapy Unit, Bari, Italy
[4] Politecn Torino, Dept Elect & Telecommun, Turin, Italy
[5] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy
[6] Ist Romagnoloper Studio Tumori IRST Dino Amadori, IRCCS, Meldola, Italy
[7] IRCSS Casa Sollievo Sofferenza, Dept Hematol & Bone Marrow Transplant, San Giovanni Rotondo, Italy
[8] San Martino Hosp & Univ, Dept Hematol, Genoa, Italy
[9] UOC Ematol Osped S Maria Croci, Ravenna, Italy
[10] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy
[11] Osped Santa Maria Misericordia, ASUFC, Clin Ematol, Udine, Italy
[12] Osped Businco Cagliari, Ematol & CTMO, Cagliari, Italy
[13] ASL Lecce, PO V Fazzi, UOC Ematol & Trapianto Cellule Staminali, Lecce, Italy
[14] AUSL IRCCS Reggio Emilia, Hematol, Reggio Emilia, Italy
[15] Osped Guglielmo Saliceto, Dip Oncol & Ematol, Unita Operat Ematol, Piacenza, Italy
[16] CRO Aviano, IRCCS, Dept Med Oncol, Aviano, Italy
[17] AULSS Osped Angelo, UO Ematol, Chirignago Zelarino, Italy
[18] Humanitas Gavazzeni, Oncol Unit, Bergamo, Italy
[19] SC Ematol Azienda Ospedaliera Santi Antonio & Bia, Alessandria, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C016
引用
收藏
页码:18 / 18
页数:1
相关论文
共 50 条
  • [41] TP53 AND KMT2D MUTATIONS PREDICT PFS IN MCL PATIENTS TREATED WITH HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION: RESULTS FROM THE MCL0208 PHASE III TRIAL FROM FONDAZIONEITALIANA LINFOMI (FIL)
    Ferrero, S.
    Rossi, D.
    Bruscaggin, A.
    Ghione, P.
    Di Rocco, A.
    Spina, V.
    Stefoni, V.
    Ciccone, G.
    Barbero, D.
    Monitillo, L.
    Gomes da Silva, M.
    Santoro, A.
    Molinari, A.
    Ferreri, A.
    Piccin, A.
    Cortelazzo, S.
    Ladetto, M.
    Gaidano, G.
    HAEMATOLOGICA, 2016, 101 : S58 - S58
  • [42] Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
    Merli, Michele
    Luminari, Stefano
    Farina, Lucia
    Cocito, Federica
    Defrancesco, Irene
    Gini, Guido
    Arcari, Annalisa
    Scapinello, Greta
    Gentile, Massimo
    Goldaniga, Maria
    Loseto, Giacomo
    Cencini, Emanuele
    Greco, Antonino
    Molinari, Anna Lia
    Ferrario, Andrea
    Bianchi, Benedetta
    Mora, Barbara
    Bertu, Lorenza
    Saturni, Vincenzo
    Bergamini, Fabio
    Fabbri, Nicole
    Rossi, Francesca Gaia
    Bolis, Silvia
    Passamonti, Francesco
    Arcaini, Luca
    BONE MARROW TRANSPLANTATION, 2020, 55 (12) : 2350 - 2353
  • [43] Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience
    Massaro, Fulvio
    Pavone, Vincenzo
    Stefani, Piero Maria
    Botto, Barbara
    Pulsoni, Alessandro
    Patti, Caterina
    Cantonetti, Maria
    Visentin, Andrea
    Scalzulli, Potito Rosario
    Rossi, Andrea
    Galimberti, Sara
    Cimminiello, Michele
    Gini, Guido
    Musso, Maurizio
    Sorio, Marco
    Arcari, Annalisa
    Zilioli, Vittorio Ruggero
    Luppi, Mario
    Mannina, Donato
    Fabbri, Alberto
    Pietrantuono, Giuseppe
    Annibali, Ombretta
    Tafuri, Agostino
    Prete, Eleonora
    Mule, Antonino
    Barbolini, Elisa
    Marcheselli, Luigi
    Luminari, Stefano
    Merli, Francesco
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (01) : 31 - 39
  • [44] Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
    Michele Merli
    Stefano Luminari
    Lucia Farina
    Federica Cocito
    Irene Defrancesco
    Guido Gini
    Annalisa Arcari
    Greta Scapinello
    Massimo Gentile
    Maria Goldaniga
    Giacomo Loseto
    Emanuele Cencini
    Antonino Greco
    Anna Lia Molinari
    Andrea Ferrario
    Benedetta Bianchi
    Barbara Mora
    Lorenza Bertù
    Vincenzo Saturni
    Fabio Bergamini
    Nicole Fabbri
    Francesca Gaia Rossi
    Silvia Bolis
    Francesco Passamonti
    Luca Arcaini
    Bone Marrow Transplantation, 2020, 55 : 2350 - 2353
  • [45] A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi
    Olivieri, Jacopo
    Mosna, Federico
    Pelosini, Matteo
    Fama, Angelo
    Rattotti, Sara
    Giannoccaro, Margherita
    Carli, Giuseppe
    Tisi, Maria Chiara
    Ferrero, Simone
    Sgherza, Nicola
    Mazzone, Anna Maria
    Marino, Dario
    Calimeri, Teresa
    Loseto, Giacomo
    Saraceni, Francesco
    Tomei, Gabriella
    Sica, Simona
    Perali, Giulia
    Codeluppi, Katia
    Billio, Atto
    Olivieri, Attilio
    Orciuolo, Enrico
    Matera, Rossella
    Stefani, Piero Maria
    Borghero, Carlo
    Ghione, Paola
    Cascavilla, Nicola
    Lanza, Francesco
    Chiusolo, Patrizia
    Finotto, Silvia
    Federici, Irene
    Gherlinzoni, Filippo
    Centurioni, Riccardo
    Fanin, Renato
    Zaja, Francesco
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1814 - 1822
  • [46] Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi
    Nassi, Luca
    De Sanctis, Vitaliana
    Loseto, Giacomo
    Gerardi, Chiara
    Allocati, Eleonora
    Ciavarella, Sabino
    Minoia, Carla
    Guarini, Attilio
    Bari, Alessia
    CANCERS, 2022, 14 (03)
  • [47] Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)
    Zaja, Francesco
    Volpetti, Stefano
    Chiappella, Annalisa
    Salvi, Flavia
    Carella, Angelo M.
    Ibatici, Adalberto
    Piccaluga, Pier Paolo
    Pileri, Stefano A.
    Rossi, Davide
    Zinzani, Pier Luigi
    Patti, Caterina
    Vitolo, Umberto
    D'Arco, Alfonso
    Tucci, Alessandra
    Franceschetti, Silvia
    Evangelista, Andrea
    Lenti, Valentina
    Fanin, Renato
    Levis, Alessandro
    BLOOD, 2014, 124 (21)
  • [48] High-dose chemotherapy with peripheral blood stem cell transplantation (HDC/PBSCT) for mantle cell lymphoma (MCL).
    Frakes, L
    Miller, W
    McMillan, R
    Meisenberg, B
    BLOOD, 1996, 88 (10) : 3859 - 3859
  • [49] Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).
    Feldman, T.
    Mato, A. R.
    Zielonka, T.
    Masood, A.
    Goldberg, S.
    Rowley, S. D.
    Donato, M.
    Siegel, D. S.
    Pecora, A.
    Goy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma
    Laudi, Noel
    Arora, Mukta
    Burns, Linda
    McGlave, Philip
    Miller, Jeffrey
    Bohac, Gerald
    Rogers, Tyson
    Barker, Juliet
    Coad, James
    Weisdorf, Daniel
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 519 - 524